Service providers

ATLANGRAM

Solution provided
Technological/Validation solutions
Supplier indentity
General description
Research & Development in Biotechnology and Post-Market Studies
Type of supplier
Service Provider - CMO / CRO, Biotechnology R&D Company - Diagnostics / Devices and Diagnostics Services
Sector of activity:
Business development, Business Services, Animal models, Bacteriology, Drug Discovery / Research & Development
Activity description
Services provided
Therapeutic Efficacy Models, * Rabbit Pneumonia Model: P. aeruginosa, * Rabbit Endocarditis Model: E. faecalis, S. aureus (MRSA, MSSA), P. aeruginosa, E. coli, K. pneumonie, Enterobacter, Serratia, Corynebacterium, * Rabbit Osteomyelitis Model: S. aureus (MRSA), * Mouse Pneumonia Model: P. aeruginosa, S. aureus (MRSA,MSSA), A. baumannii, * Mouse urinary Tract Infection: E. coli, * Mouse Peritonitis / Sepsis: Gram +, Gram -| * Mouse Thigh Infection: : S. aureus, E. coli, K. pneumoniae | In vivo Parameters, * Human pharmacokinetic simulation: rabbit, * Levels: plasma, tissues, fluids, * ED50 determination: peritonitis/sepsis, * Appropriate frequency and/or dose administration, * Survival and/or CFU endpoints, * Cytokines quantification: TNF-?, IL 1?, MIP-2, * Myeloperoxydase activity, In vitro antimicrobial and Biofilm assays, * Determination of MICs, MBCs, MPC, PAE, Killing Curves, * Combinations studies: FIC index, Time-Kill & Dynamic checkerboard methods, * Biofilm activity: MICs, Time-Kill studies, Nanoparticles, phages, biomaterials loaded with antibiotics, Ex vivo activity in complex media type fibrin clots
Terms of availability for SMEs
Quality labels and accreditations
Contact information
Name
Amokrane REGHAL
Function
CEO
Phone number
+33 (0)2 36 56 90 01
Website
Address

Agenda

Mo Tu We Th Fr Sa Su
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
31